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Abstract
Melatonin (N-acetyl-5-methoxytryptamine) is secreted during the dark hours at night by pineal gland, and it
regulates a variety of important central and peripheral actions related to circadian rhythms and reproduction. It has
been believed that melatonin regulates ovarian function by the regulation of gonadotropin release in the
hypothalamus-pituitary gland axis via its specific receptors. In addition to the receptor mediated action, the
discovery of melatonin as a direct free radical scavenger has greatly broadened the understanding of melatonin’s
mechanisms which benefit reproductive physiology. Higher concentrations of melatonin have been found in
human preovulatory follicular fluid compared to serum, and there is growing evidence of the direct effects of
melatonin on ovarian function especially oocyte maturation and embryo development. Many scientists have
focused on the direct role of melatonin on oocyte maturation and embryo development as an anti-oxidant to
reduce oxidative stress induced by reactive oxygen species, which are produced during ovulation process. The
beneficial effects of melatonin administration on oocyte maturation and embryo development have been
confirmed by in vitro and in vivo experiments in animals. This review also discusses the first application of
melatonin to the clinical treatment of infertile women and confirms that melatonin administration reduces
intrafollicular oxidative damage and increase fertilization rates. This review summarizes our recent works and new
findings related to the reported beneficial effects of melatonin on reproductive physiology in its role as a reducer
of oxidative stress, especially on oocyte maturation and embryo development.
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Intoduction
Reactive oxygen species (ROS) are formed continuously
in cells as a consequence of both oxidative biochemical
reactions and external factors. While physiological levels
of oxygen are necessary for cells to live, ROS such as
superoxide radical (O2-), hydroxyl radical (·OH), and
hydrogen peroxide (H2O2) are generated from oxygen.
ROS can regulate cell function by controlling the pro-
duction and activation of substances that have biological
activities and by activating key downstream cell-signal-
ing pathways [1-3]. However, surplus generation of ROS
interact with lipid, protein and nucleic acid, resulting in
a loss of membrane integrity, structural or functional
changes in proteins, and damage in nucleic acids.
Therefore, an increase in the production of ROS have
detrimental effects on cell function and contributes sig-
nificantly to several diseases, including those that may
compromise reproduction and fertility [4].
ROS are produced within the follicle, especially during
the ovulatory process. ROS play a physiological role in
the process of ovulation, e.g. follicle rupture. However,
an excessive amount of ROS cause oxidative stress and
may damage oocyte and granulosa cells. Accumulating
data have shown that ROS accelarate oocyte aging and
deteriorate oocyte quality [5,6]. On the other hand, anti-
oxidant defense systems, such as superoxide dismutase
(SOD) or glutathione (GSH), are present in follicles.
The balance between ROS and antioxidants within the
follicle seems to be critical to the function of oocyte and
granulosa cells.
Melatonin, a hormone mainly synthesized in the
pineal gland, has multiple effects on a number of
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any medium, provided the original work is properly cited.different physiological processes. Melatonin plays a key
role in a variety of important physiological functions,
including circadian rhythms [7], reproductive [8], neu-
roendocrine [9], cardiovascular [10], neuroimmunologi-
cal [11], oncostatic actions [12]. We already reported
that melatonin plays a role in lipid metabolism [13],
pregnancy and parturition time [14-16], and corpus
luteum (CL) function [17]. Some effects of melatonin
are mediated through specific membrane receptors, but
many of them seem to rely on its potential as a direct
free radical scavenger, a process that requires no recep-
tor. A growing number of studies have demonstrated
that melatonin is a powerful direct scavenger of free
radicals. In contrast to the majority of other known
radical scavengers, melatonin is multifunctional and a
universal antioxidant. The high lipophilicity and hydro-
philicity of melatonin permits its rapid transfer into
other organs and fluids, and melatonin can easily pass
through cell membranes. Interestingly, high levels of
melatonin have been found in human follicular fluid
[18,19]. We already reported that human preovulatory
follicular fluids contain higher concentrations of melato-
nin than of plasma and the melatonin concentrations in
follicular fluids increased depending on follicular growth
[20]. Although the physiological roles of melatonin in
follicular fluid have not been understood, it is possible
that melatonin is the most effective antioxidant in the
follicle. The purpose of this current review is to sum-
marize recent developments in the field of melatonin
research, with a focus on how melatonin directly pro-
tects oocyte from oxidative stress within the ovarian
follicle.
Ovulation and reactive oxygen species (ROS)
ROS is locally produced during follicular rupture and
may be involved in the ovulation process. Luteinizing
hormone (LH) surge induces a dissolution of the base-
ment membrane between the granulosa and theca
interna layers and an expansion of the theca capillaries
into the avascular granulosa cell layer to form a dense
network of capillaries. Macrophages and neutrophiles
are well-documented to reside in follicles; it is also well-
documented that they are taken into the follicles
[21,22]. Tremendous amounts of free radicals are pro-
duced within the follicle not only by macrophages and
neutrophiles but also by the endothelial cells of the
capillaries. Locally produced ROS seems to have an
essential role on follicle rupture, and ROS also have an
important role as second messengers modulating the
expression of genes that govern physiological processes
of oocyte maturation [23,24]. However, excess ROS can
also be responsible for oxidative stress; they can damage
molecules and structures of oocyte and granulosa cells
within the follicle. ROS must be continuously
deactivated to keep only the small amount necessary to
maintain normal cell function. Follicular components,
cumulus cells and the follicular fluid, may protect the
oocytes from the damaging effects of ROS [25-27]. It is
well recognized that endogenous antioxidant enzymes
and non-enzymatic antioxidants are present in the folli-
cles and are working to combat or reduce ROS. Failure
or deficiency of these oocyte defenses could result in
accumulation of ROS and the development of oxidative
stress with resultant oocyte damage [28]. Additionally,
ROS may be overproduced in response to several condi-
tions, such as infections, inflammation, chemotherapy,
radiation, and superovulation as an infertility therapy.
To assess whether the oxidative stress would develop
within the follicle during the ovulation process, intrafol-
licular concentrations of oxidative stress markers were
measured in pregnant mare serum gonadotropin
(PMSG) treated immature rats (Figure 1). Intrafollicular
concentration of 8-hydroxy-2’-deoxyguanosine (8-
OHdG), as a DNA-related oxidative stress marker, was
increased after human chorionic gonadotropin (hCG)
injection. The 8-OHdG concentration was significantly
increased at 9 hrs after hCG injection, just before ovula-
tion. Intrafollicular concentration of hexanoyl-lysine
adduct (HEL, a biomarker of lipid peroxidation) was
also increased after hCG injection. Taking the results
into consideration, ROS is physiologically produced
within the follicles after LH surge, and the surplus ROS
which could not be scavenged by antioxidants is respon-
sible for oxidative stress during ovulation process. Oxi-
dative stress may be a cause of poor oocyte quality. ROS
such as superoxide radical (O2-), hydroxyl radical (·OH),
hydrogen peroxide (H2O2) are known to be detrimental
to the oocyte. They cause deterioration of cell mem-
brane lipids, destroy DNA and induce two-cell block,
apoptosis, and inhibition of fertilization in mouse and
hamster [27,29,30]. Chao et al. [31] investigated oocyte
competence after ovarian hyperstimulation in mice.
Ovarian mitochondrial DNA mutation, an increase in
mtDNA large scale deletions, and oxidative damage, an
increase in 8-OHdG, were seen after repeated ovarian
stimulation by exogenous gonadotrophin. Also, higher
levels of the oxidant H2O2 have been reported in frag-
mented human embryos compared with non-fragmented
embryos and unfertilized oocytes [6]. These results sug-
gested that excessive oxidative stress may be a cause for
poor oocyte quality.
It is well documented that antioxidant enzymes, such
as (SOD), glutathione peroxidase (GPx) and catalase,
and non-enzymatic antioxidants, such as vitamin E, vita-
min C, glutathione, uric acid and albumin, are present
in the follicles [4,5,32]. Reduced antioxidant enzyme
levels, such as GPx, are reported in the follicular fluids
of women with unexplained infertility [33]. Another
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in follicular fluid efficiently reduced DNA damage
caused by oxidative stress in porcine oocytes and cumu-
lus cells, resulting in successful fertilization and develop-
ment to the blastocyst stage after in vitro insemination;
however, these abilities were interrupted by the SOD
inhibitor [26]. When mice were given antioxidant sup-
plements (vitamins C and E), an increased number of
normal MII oocytes and decreased percentage of apop-
totic oocytes were observed in comparison with the con-
trol group [34]. The balance between ROS and
antioxidants within the follicle seems to be critical for
oocytes.
Melatonin as a free radical scavenger
Although melatonin exerts effects through its receptors,
melatonin also can act as a powerful direct free radical
scavenger. In 1993, melatonin was discovered to func-
tion as a direct free radical scavenger when it was
shown to detoxify the highly reactive hydroxyl radical
(·OH) [35,36]. Since then, many reports have confirmed
the ability of melatonin to reduce oxidative stress
[37,38]. In these investigations, melatonin was found to
scavenge both oxygen- and nitrogen-based reactants
[39,40] in several subcellular organelles [41]. Melatonin
works in a variety of ways to reduce the levels of oxida-
tive stress. It has been shown that melatonin has the
capability of quenching reactive oxygen as well as reac-
tive nitrogen species including superoxide radical (O2-),
hydroxyl radical (·OH), singlet oxygen (
1O2), hydrogen
peroxide (H2O2), hypochlorous acid (HOCl), nitric oxide
(NO·) and the peroxynitrite anion (ONOO-) [41-44].
Three key players are involved in ROS damage to cells:
hydrogen peroxide (H2O2), superoxide radical (O2-),
and hydroxyl radical (·OH). H2O2 and superoxide radi-
cals (O2-) are thought to create less damage than hydro-
xyl radical (·OH), however, in the presence of free iron,
specifically ferrous iron, H2O2 is converted to hydroxyl
radical (Fenton reaction). Hydroxyl radical (·OH) is the
most potent free radicals and is known to produce
damage to all biological membranes and DNA. Melato-
nin can easily pass through cell membranes because of
its properties of lipophilicity and hydrophilicity, and it
has been demonstrated that a high levels of melatonin
exist not only in cytoplasm but also beside the nucleus.
The antioxidant properties of melatonin as a cell protec-
tor have been extensively studied and a previous report
demonstrated that the melatonin’s ability to detoxify the
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Figure 1 Changes in intrafollicular concentrations of 8-hydroxy-2’-deoxyguanosine (8-OHdG) and hexanoyl-lysine adduct (HEL) during
ovulation process. Immature (3 wks) rats received a subcutaneous injection of 20 units of pregnant mare serum gonadotropin (PMSG) to
stimulate the multiple follicles. 48 hrs after PMSG injection, human chorionic gonadotropin (HCG) injection was performed to induce ovulation.
The ovaries were quickly removed 0, 3, 6 and 9 hr after HCG injection and were transferred to the 500 μl of 0.01 M PBS buffer. Follicular fluids
were collected by puncturing ovarian follicles with a 26-gauge needle under dissecting microscope and centrifuged at 300 g for 10 min, and
the supernatants were collected and stored at -80C until assay. 8-OHdG and HEL concentrations were measured using ELISA kit. Data are shown
as the mean ± SEM for 4 rats. *: p < 0.05 versus 0 h, 3 h.
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vengers including vitamin C and vitamin E [37].
Not only is melatonin itself a direct free radical sca-
venger, but also metabolites that are formed during
these interactions, i.e., cyclic 3-hydroxmelatonin, N1-
acetyl-N2-formyl-5-methoxykynuramine (AFMK) and
N1-acetyl-5-methoxykynuramine (AMK), are likewise
excellent scavengers of reactive species [40,41,45-47]. In
addition, melatonin has a high capability to detoxify
ROS and suppresses the oxidative effect indirectly by
enhancing the production of endogenous antioxidants.
Melatonin has been stimulates activities and mRNA
levels of antioxidative enzymes including (SOD), (GPx),
and catalase [48,49]. Thereby, these multiple actions of
melatonin protect cells from ROS-mediated lipid peroxi-
dation, protein destruction and nuclear DNA damage
[50-54].
Melatonin and reproduction
The roles of melatonin in reproduction are focused on
its direct actions in the ovary. Melatonin can pass
through all cell membranes and enter all tissues because
of its lipophilic property, however, it specifically concen-
trates in the ovary when injected systemically [55]. High
levels of melatonin are found in human preovulatory
follicular fluid at concentrations which are higher than
serum levels [18,19]. We previously demonstrated that
melatonin concentrations in the ovary showed a similar
phasic variation with high levels during mid-dark and
low levels during mid-light, just as in the pineal gland
and serum of hamsters [56]. These concentrations were
highest in proestrus, when the ovary has preovulatory
follicles, during the estrus cycle. We also found the con-
centrations of preovulatory follicular fluid (> 18 mm) in
in-vitro fertilization and embryo transfer (IVF-ET)
patients are significantly higher than in small (10-12
mm) and middle follicles (15-16 mm) [20]. These results
demonstrated that melatonin levels in ovarian follicles
increase depending on follicular growth. We presume
that the majority of melatonin found in follicular fluid
enters the follicle from blood because no clear mRNA
expression of NAT (the rate-limiting enzyme of melato-
nin) could be found in the granulosa cells of rats and
humans (unpublished data), and administration of mela-
tonin dose dependently increased melatonin concentra-
tions in the follicle in human (data not shown).
Increased melatonin in follicular fluid seems to have an
important role in ovulation.
Melatonin, oocyte quality, and embryo development
High quality oocytes produce well-developed embryos.
After fertilization, ooplasm becomes the embryo cyto-
plasm, but the spermatozoon’s participation in this pro-
cess is minimal. It has been thought that the first steps
of embryogenesis are controlled exclusively by maternal
information present in the oocyte. For this reason, the
quality of oocytes is a key factor in determining the
quality of the early steps of embryo development.
Oocyte maturation begins with the resumption of meio-
sis, and oocytes are arrested at prophase of the first
meiotic division. Only fully grown oocytes can resume
meiosis in response to LH surge. Oocytes pass through
the first meiotic division and then become arrested at
metaphase of the second meiotic division until fertiliza-
tion. During this long period of meiotic maturation,
oocyte accumulate molecules of mRNA, proteins, lipid
and sugars as well as oxidative stress.
Oxidative stress in the oocyte caused by ROS must be
limited in order for a good embryo to be produced.
ROS induce lipid peroxidation of membranes and DNA
damage in the oocyte and are expected to cause harmful
effects in cell division, metabolite transport, and mito-
chondrial function [28]. We recently reported the direct
effect of ROS and melatonin on oocyte maturation [57].
To investigate the effects of H2O2 on oocyte maturation,
the denuded oocytes from immature mice treated with
PMSG were cultured in the incubation medium with
various concentrations of H2O2. After 12 hr incubation,
oocytes with the first polar body (MII stage oocytes)
were counted. The percentage of the mature oocytes
(MII stage oocytes with a first polar body) was signifi-
cantly decreased by the addition of H2O2 in a dose-
dependent manner (> 200 μM). When oocytes were
incubated with melatonin in the presence of H2O2 (300
μM), melatonin dose-dependently blocked the inhibitory
effect of H2O2 on oocyte maturation, and there was a
significant effect at the concentration of 10 ng/mL of
melatonin. To further investigate the intra-cellular role
of melatonin, oocytes were incubated with dichlorofluor-
escein (DCF-DA). The nonfluorescent DCF-DA was oxi-
dized by intracellular ROS to form the highly
fluorescent DCF, intracellular ROS formation was visua-
lized by fluorescence image, and fluorescence intensity
was analyzed. When oocytes were incubated without
H2O2, there was no observable fluorescent intensity.
However, high fluorescence intensities were observed in
the presence of H2O2 (300 μm). The increased fluores-
cence intensity of oocytes incubated with H2O2 was sig-
nificantly decreased by melatonin treatment (Figure 2).
These results suggest that H2O2 inhibits oocytes
maturation by producing ROS, but melatonin demon-
strated protective activity against oxidative stress caused
by H2O2. Recently, Kang et al., [58] investigated the
effects of melatonin on the maturation of porcine
oocytes. Oocytes from antral follicles were incubated in
the medium with or without melatonin supplementa-
tion. Melatonin supplementation (10 ng/ml) during in-
vitro maturation resulted in a greater proportion of
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oocytes had significantly lower levels of ROS than con-
trol (without melatonin treatment) oocytes.
The ability of melatonin to promote embryo develop-
ment in different species has been reported. When inse-
minated mouse embryos were cultured in the medium
with melatonin (10
-8-10
-4 M), increased fertilization and
blastocyst rates were observed [59]. Rodriguez-Osorio et
al. [60] demonstrated the effects of melatonin on in-
vitro porcine embryo development. Melatonin supple-
mentation (10
-9 M) had a positive effect on the fertiliza-
tion rates of inseminated porcine embryos that were
cultured. Although blastocyst rates were not increased
by melatonin, the number of blastocyst cells in the mel-
atonin-supplemented group was significantly higher
than in the control group. When the oocytes recovered
from porcine follicles were incubated in the medium
with melatonin (10
-7 M), fertilization rate, blastocyst
rate and the number of blastocyst cells were significantly
higher than that of the control (without melatonin) [61].
The effect of melatonin on embryo development seems
to be, at least in part, caused by its action as an antioxi-
dant, as Papis et al. [62] demonstrated that the beneficial
effects of melatonin on bovine embryo development was
observed not in a low oxygen environment but in a high
oxygen environment where free radicals are easily pro-
duced. We recently confirmed the benefit of melatonin
treatment to infertility women who underwent an IVF-
ET program. When women were treated with 3 mg of
melatonin daily from day 5 of the previous menstrual
cycle until the day of oocyte retrieval, the percentage of
good embryos (day 2 after insemination) was signifi-
cantly higher compared to the control (without melato-
nin treatment) cycle (Figure 3). These data suggest that
melatonin may be involved in oocyte maturation and
embryo development.
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Figure 2 The effect of melatonin on intracellular ROS production.I m m a t u r e( 3w k s )I C Rm i c ew e r eg i v e na ni n j e c t i o no f2 0u n i t so f
pregnant mare serum gonadotropin (PMSG) to stimulate the development of multiple follicles. Oocytes were collected by puncturing ovarian
follicles after 48 hrs PMSG injection, and then the surrounding cumulus cells were removed. Oocytes were incubated with 1 mM H2O2 for 10
min in the presence of melatonin (0, 1 μg/ml, 100 μg/ml). Intracellular ROS were detected using an intracellular dye (dichlorofuorescin:DCF-DA).
The nonfluorescent DCF-DA is oxidized by intracellular ROS to form the highly fluorescent DCF, intracellular ROS formation was visualized by
fluorescence image and fluorescence intensity was analyzed using MetaMorph software. (A) H2O2 (1 mM); (B) H2O2 (1 mM)+ melatonin (1 μg/ml);
(C) H2O2 (1 mM)+ melatonin (100 μg/ml); (D) Fluorescence intensity in the oocytes. Data are shown as the mean ± SEM for (6-9 oocytes). *: p <
0.05 versus H2O2 (1 mM).
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As summarized above, a growing amount of literature
has demonstrated that melatonin and/or melatonin
treatment may have a beneficial effect on oocyte
maturation and embryo development. Poor oocyte qual-
ity is one of the most intractable causes of infertility in
women. Melatonin treatment can be a useful infertility
treatment and, therefore recently has been applied to
infertility patients for the first time.
To document an association between melatonin and
ovarian oxidative stress, human follicular fluids were
sampled during oocyte retrieval for the purpose of IVF-
ET and concentrations of melatonin and 8-OHdG were
measured. The study revealed an inverse correlation
between intra-follicular concentrations melatonin and 8-
OHdG, suggesting that melatonin in the follicle diffuses
into the cumulus and oocytes to protect them from free
radical damage. When patients were given a 3 mg tablet
of melatonin orally at 22:00 hr from the fifth day of the
previous menstrual cycle until the day of oocyte retrie-
val, intra-follicular concentrations of melatonin rose
from 112 pg/ml in the control cycle (without melatonin
treatment) to 432 pg/ml after daily melatonin treatment.
Intra-follicular concentrations of 8-OHdG and HEL, a
damaged lipid product, were decreased after melatonin
treatment compared to those in the prior cycle. The
result demonstrates that melatonin treatment reduces
intra-follicular oxidative damage. To investigate the clin-
ical usefulness of melatonin administration, the effect of
melatonin treatment on clinical outcome of IVF-ET was
examined for 115 patients who failed to become preg-
nant in the previous IVF-ET cycle with a low fertiliza-
tion rate (< 50%). In 56 patients with melatonin
treatment, the fertilization rate (50.0 ± 38.0%) was
markedly improved compared with the previous IVF-ET
cycle (20.2 ± 19.0%), and 11 of 56 patients (19.6%)
achieved pregnancy. On the other hand, in 59 patients
who were not given melatonin, the fertilization rate
(22.8 ± 19.0% vs 20.9 ± 16.5%) was not significantly
changed, and only 6 of 59 patients (10.2%) achieved
pregnancy. These results show that melatonin adminis-
tration increases intra-follicular melatonin
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Figure 3 Effect of melatonin treatment on embryo development in patients who underwent IVF-ET program. Nine patients undergoing
IVF-ET who failed to become pregnant in the prior IVF-ET cycle were given a 3 mg tablet of melatonin (KAL, Park City, UT, USA) orally at 22:00
hr from the fifth day of the previous menstrual cycle until the day of oocyte retrieval. Embryo quality was assessed according to Veeck criteria at
2 days after insemination, and Veeck I or II embryo was defined as a good embryo. Rate of good embryos was calculated; divide the number of
good embryos (VeeckI or II) by the number of oocytes retrieved. Data are shown as the mean ± SEM. *: p < 0.05 versus control cycle.
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and elevates fertilization and pregnancy rates.
To our knowledge, our study represents the first clini-
cal usefulness of melatonin treatment for infertility
patients. Melatonin is likely to become a treatment for
improving oocyte quality for women who cannot
become pregnant because of poor oocyte quality.
Conclusions
The discovery of melatonin as a direct free radical sca-
venger has greatly broadened the understanding of its
multiple physiological roles. The new findings regarding
the potential role of melatonin in reproductive physiol-
ogy have been also increasing. Melatonin is applicable
to the regulation of seasonal reproductive events in
photoperiod dependent breeding mammals, and it
seems to be receptor mediated mechanism in hypothala-
mus and pituitary gland. However, recently many
researchers have begun to study the local role of mela-
tonin as an antioxidant. We focused on intra-follicular
role of melatonin in the ovary. Melatonin, secreted by
pineal gland, is taken up into the follicular fluid from
the blood. ROS produced within the follicles, especially
during the ovulation process, were scavenged by
melatonin, and reduced oxidative stress may be involved
in oocyte maturation and embryo development (Figure
4). Our clinical study demo n s t r a t e dt h a tm e l a t o n i n
treatment for infertility women increases intra-follicular
melatonin concentrations, reduces intra-follicular oxida-
tive damage and elevates fertilization and pregnancy
rates. It should be noted that melatonin treatment could
become a new cure for improving oocyte quality in
infertility patients, this is consistent with the most
detailed review which was reported recently [63]. The
safety of exogenous melatonin for humans has been
shown in many studies [64,65]. It has also been reported
that melatonin have no detrimental effects on mouse
and rat embryo development during toxicity tests that
were performed both in-vitro and in-vivo [58,66,67].
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